Apoptosis: a barrier against cancer no more?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. How cell death shapes cancer.Cell death & disease · 2015
   Review
2. Lessons from gain- and loss-of-function models of pro-survival Bcl2 family proteins: implications for targeted therapy.The FEBS journal · 2015
   Review
3. Apoptosis and necrosis in the liver.Comprehensive Physiology · 2013
   Review
4. The p53-PUMA axis suppresses iPSC generation.Nature communications · 2013
   Article
5. PUMA, a critical mediator of cell death--one decade on from its discovery.Cellular & molecular biology letters · 2012
   Review

Corrections and comments

• Comment on
  PUMA-mediated apoptosis drives chemical hepatocarcinogenesis in mice.2011

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as